Search Results - Evandro de Azambuja
- Showing 1 - 17 results of 17
-
1
-
2
-
3
-
4
-
5
Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment by Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada
Published in Therapeutic Advances in Medical Oncology (2023-07-01)Get full text
Article -
6
-
7
Medication Guide: A web application for personalized benefit-risk assessments of OTC analgesics by Philipp Lampert, Evandro de Azambuja, Juan Manuel Escalona Rosales, Jennifer von Stebut-Marx, Jakob Fenske, Carsten Rendenbach, Reinhold Kreutz
Published in SoftwareX (2025-09-01)Get full text
Article -
8
Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy by C. Florin Pop, Clémence Ortega, Mathilde Lecomte, Paulus Kristanto, Chirine Khaled, Filip De Neubourg, Antoine Desmet, Evandro De Azambuja, Denis Larsimont, Isabelle Veys
Published in npj Breast Cancer (2025-05-01)Get full text
Article -
9
Antibody–drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis by Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert, Jonathan Priantti, Caio Ernesto do Rego Castro, Lucas Vian, Paolo Tarantino, Evandro de Azambuja, Ludimila Cavalcante
Published in Therapeutic Advances in Medical Oncology (2024-11-01)Get full text
Article -
10
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer by Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
Published in npj Breast Cancer (2021-05-01)Get full text
Article -
11
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer by Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bliss, Judith Kroep, Marco Colleoni, Fausto Petrelli, Lucia Del Mastro, Alvaro Moreno-Aspitia, Martine Piccart, Marianne Paesmans, Evandro de Azambuja, Matteo Lambertini
Published in npj Breast Cancer (2022-07-01)Get full text
Article -
12
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study by Karen Van Baelen, Ha-Linh Nguyen, François Richard, Gitte Zels, Maria Margarete Karsten, Guilherme Nader-Marta, Peter Vermeulen, Luc Dirix, Adam David Dordevic, Evandro de Azambuja, Denis Larsimont, Marion Maetens, Elia Biganzoli, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Giuseppe Floris, Christine Desmedt
Published in Breast Cancer Research (2025-06-01)Get full text
Article -
13
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study by Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccinini, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
Published in Breast (2024-10-01)Get full text
Article -
14
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) by Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators
Published in Breast Cancer Research (2024-10-01)Get full text
Article -
15
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast ca... by Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Francois P. Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine Piccart-Gebhart
Published in Nature Communications (2023-12-01)Get full text
Article -
16
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomize... by Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Francois P. Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine Piccart-Gebhart
Published in Nature Communications (2023-11-01)Get full text
Article -
17
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer by Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, Geert Martens, Jean-Luc Canon, Gabriela Beniuga, Guy Froyen, Jacques Van Huysse, Rebecca De Pauw, Hans Prenen, Suzan Lambin, Lore Decoster, Freya Vaeyens, Sylvie Rottey, Pieter-Jan Van Dam, Lynn Decoster, Annemie Rutten, Max Schreuer, Siebe Loontiens, Joni Van der Meulen, Jeroen Mebis, Kristof Cuppens, Sabine Tejpar, Isabelle Vanden Bempt, Jacques De Grève, David Schröder, Cédric van Marcke, Marc Van Den Bulcke, Evandro de Azambuja, Kevin Punie, Brigitte Maes
Published in npj Precision Oncology (2025-03-01)Get full text
Article